Stocks News

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Dec 5, 2024
- Agenus Announces Strategic Realignment to Focus on Core Programs and Significantly Reduce Costs, from 7:30AM ET on Thursday Dec 05, 2024 by Dow Jones
  7:30AM ET on Thursday Dec 05, 2024 by Dow Jones
  Companies Mentioned: AGEN
  
  Agenus Announces Strategic Realignment to Focus on Core Programs and Significantly Reduce Costs
  LEXINGTON, Mass.--(BUSINESS WIRE)--December 05, 2024--
  Agenus Inc., a leader in immuno-oncology, today announced further details of its strategic realignment aimed at streamlining operations, strengthening its financial position, and prioritizing the advancement of its most impactful programs as it prepares for 2025. Reductions are designed to reduce cash burn to $100 million in FY 2025. This initiative follows the successful closing of a $22 million mortgage secured by key real estate assets, providing the company with enhanced operational flexibility during this pivotal period.
Nov 29, 2024
- DJ Agenus Price Target Maintained With a $7.00/Share by HC Wainwright & Co., from 4:52AM ET on Friday Nov 29, 2024 by Dow Jones
  4:52AM ET on Friday Nov 29, 2024 by Dow Jones
  Companies Mentioned: AGEN
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/AGEN/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 29, 2024 04:52 ET (09:52 GMT)
Nov 27, 2024
- Agenus Secures $22 Million Mortgage, Plans Operational Realignment; Shares Jump, from 10:12AM ET on Wednesday Nov 27, 2024 by MT Newswires
  10:12AM ET on Wednesday Nov 27, 2024 by MT Newswires
  Companies Mentioned: AGEN
  10:12 AM EST, 11/27/2024 (MT Newswires) -- Agenus (AGEN) said Wednesday it has secured a $22 million mortgage backed by two California properties and is implementing an operational realignment plan to enhance its focus on botensilimab/balstilimab in...
- *DJ Agenus Secures $22M Mortgage and Announces Strategic Operational Realignment, from 8:15AM ET on Wednesday Nov 27, 2024 by Dow Jones
  8:15AM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: AGEN
- Agenus Secures $22 Million Mortgage and Announces Strategic Operational Realignment, from 8:15AM ET on Wednesday Nov 27, 2024 by Dow Jones
  8:15AM ET on Wednesday Nov 27, 2024 by Dow Jones
  Companies Mentioned: AGEN
  
  Agenus Secures $22 Million Mortgage and Announces Strategic Operational Realignment
  LEXINGTON, Mass.--(BUSINESS WIRE)--November 27, 2024--
  Agenus Inc. ("Agenus" or the "Company") (Nasdaq: AGEN), an immuno-oncology company focused on innovation has successfully secured a $22 million non-amortizing mortgage backed by its Berkeley-based Biologics CMC facility ("901 Heinz") and its 66-acre biomanufacturing-zoned property in Vacaville, California. Facilitated by L&L Capital, the transaction yields $20 million in net proceeds after closing costs and interest reserve, bolstering the company's cash position ahead of anticipated additional cash infusions in the coming months. The mortgage, structured with a two-year term, carries interest payable in a 50% cash and 50% common stock arrangement, with rates set at 12% for Year 1 and 13% for Year 2.

Dec 3, 2024
- Karyopharm Therapeutics Provides Endometrial Cancer Program Update, from 7:00AM ET on Tuesday Dec 03, 2024 by PR Newswire
  7:00AM ET on Tuesday Dec 03, 2024 by PR Newswire
  Companies Mentioned: KPTI
- Karyopharm Therapeutics Provides Endometrial Cancer Program Update, from 7:00AM ET on Tuesday Dec 03, 2024 by Dow Jones
  7:00AM ET on Tuesday Dec 03, 2024 by Dow Jones
  Companies Mentioned: KPTI
Dec 2, 2024
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 7:00AM ET on Monday Dec 02, 2024 by PR Newswire
  7:00AM ET on Monday Dec 02, 2024 by PR Newswire
  Companies Mentioned: KPTI
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 7:00AM ET on Monday Dec 02, 2024 by Dow Jones
  7:00AM ET on Monday Dec 02, 2024 by Dow Jones
  Companies Mentioned: KPTI
Nov 25, 2024
- Karyopharm to Participate at the Piper Sandler 36th Annual Healthcare Conference, from 7:00AM ET on Monday Nov 25, 2024 by PR Newswire
  7:00AM ET on Monday Nov 25, 2024 by PR Newswire
  Companies Mentioned: KPTI
- Karyopharm to Participate at the Piper Sandler 36th Annual Healthcare Conference, from 7:00AM ET on Monday Nov 25, 2024 by Dow Jones
  7:00AM ET on Monday Nov 25, 2024 by Dow Jones
  Companies Mentioned: KPTI
Nov 22, 2024
- Seres Therapeutics to Participate in Piper Sandler Healthcare Conference, from 7:00AM ET on Friday Nov 22, 2024 by Dow Jones
  7:00AM ET on Friday Nov 22, 2024 by Dow Jones
  Companies Mentioned: MCRB
Nov 20, 2024
- Karyopharm Therapeutics Appoints Kristin Abate as Chief Accounting Officer, from 5:54PM ET on Wednesday Nov 20, 2024 by MT Newswires
  5:54PM ET on Wednesday Nov 20, 2024 by MT Newswires
  Companies Mentioned: KPTI
- Karyopharm Therapeutics Announces the Appointment of Chief Accounting Officer, from 4:05PM ET on Wednesday Nov 20, 2024 by PR Newswire
  4:05PM ET on Wednesday Nov 20, 2024 by PR Newswire
  Companies Mentioned: KPTI
- Press Release: Karyopharm Therapeutics Announces the Appointment of Chief Accounting Officer, from 4:05PM ET on Wednesday Nov 20, 2024 by Dow Jones
  4:05PM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: KPTI

Agenus Inc
NASDAQ:AGENUnited States

Search Criteria

Dec 5, 2024

Agenus Announces Strategic Realignment to Focus on Core Programs and Significantly Reduce Costs, from 7:30AM ET on Thursday Dec 05, 2024 by Dow Jones

Nov 29, 2024

DJ Agenus Price Target Maintained With a $7.00/Share by HC Wainwright & Co., from 4:52AM ET on Friday Nov 29, 2024 by Dow Jones

Nov 27, 2024

Agenus Secures $22 Million Mortgage, Plans Operational Realignment; Shares Jump, from 10:12AM ET on Wednesday Nov 27, 2024 by MT Newswires

*DJ Agenus Secures $22M Mortgage and Announces Strategic Operational Realignment, from 8:15AM ET on Wednesday Nov 27, 2024 by Dow Jones

Agenus Secures $22 Million Mortgage and Announces Strategic Operational Realignment, from 8:15AM ET on Wednesday Nov 27, 2024 by Dow Jones

Peers Headlines

Dec 3, 2024

Karyopharm Therapeutics Provides Endometrial Cancer Program Update, from 7:00AM ET on Tuesday Dec 03, 2024 by PR Newswire

Karyopharm Therapeutics Provides Endometrial Cancer Program Update, from 7:00AM ET on Tuesday Dec 03, 2024 by Dow Jones

Dec 2, 2024

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 7:00AM ET on Monday Dec 02, 2024 by PR Newswire

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 7:00AM ET on Monday Dec 02, 2024 by Dow Jones

Nov 25, 2024

Karyopharm to Participate at the Piper Sandler 36th Annual Healthcare Conference, from 7:00AM ET on Monday Nov 25, 2024 by PR Newswire

Karyopharm to Participate at the Piper Sandler 36th Annual Healthcare Conference, from 7:00AM ET on Monday Nov 25, 2024 by Dow Jones

Nov 22, 2024

Seres Therapeutics to Participate in Piper Sandler Healthcare Conference, from 7:00AM ET on Friday Nov 22, 2024 by Dow Jones

Nov 20, 2024

Karyopharm Therapeutics Appoints Kristin Abate as Chief Accounting Officer, from 5:54PM ET on Wednesday Nov 20, 2024 by MT Newswires

Karyopharm Therapeutics Announces the Appointment of Chief Accounting Officer, from 4:05PM ET on Wednesday Nov 20, 2024 by PR Newswire

Press Release: Karyopharm Therapeutics Announces the Appointment of Chief Accounting Officer, from 4:05PM ET on Wednesday Nov 20, 2024 by Dow Jones